KYMRIAH
"KYMRIAH" is a word mark owned by Novartis AG, filed at the USPTO on July 28, 2017. It is registered and covers classes 5 and 44.
- Status
- Registered
- Since September 27, 2024
- Filed
- July 28, 2017
- Registered
- February 20, 2018
- Expires
- Not recorded
- Application no.
- 79219217
- Registration no.
- 5404058
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns KYMRIAH
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Novartis AG
NOVN · Switzerland
Representative
Maury M. Tepper, III
Tepper & Eyster, PLLC
What the mark covers
The products and services KYMRIAH is filed for, grouped by Nice class.
[ Pharmaceutical and biological preparations for medical diagnostic use; ] pharmaceutical and biological preparations for medical use, namely, for [ the prevention and treatment of diseases and disorders of the nervous system, the immune system * and * , the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, ] oncology [ , hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations ]
Collection and preservation of biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatment
What has happened so far
Steps recorded by the USPTO, newest first.
- Partial invalidation processed by the ib
- Partial invalidation of reg ext protection sent to ib
- Invalidation processed
- Partial invalidation of reg ext protection created
- Notice of acceptance of sec. 71 & 15 - e-mailed
- Registered - sec. 71 accepted & sec. 15 ack.
- Teas response to office action-post reg received
- Post registration action mailed - sec. 71 & 15
- Case assigned to post registration paralegal
- International registration renewed
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About KYMRIAH
Who owns the trademark "KYMRIAH"?
The USPTO trademark "KYMRIAH" (application 79219217) is owned by Novartis AG.
What is the status of "KYMRIAH"?
Its status at the USPTO is: registered.
When was "KYMRIAH" registered?
It was registered on February 20, 2018.
Get this data via the API
Everything on this page comes from the Signa API. Pull KYMRIAH and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2acb-b9f5-75a9-aef6-8cf9449d9054
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2acb-b9f5-75a9-aef6-8cf9449d9054",
"object": "trademark",
"mark_text": "KYMRIAH",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "79219217",
"filing_date": "2017-07-28",
"nice_classes": [
5,
44
],
"owners": [
{
"name": "NOVARTIS AG",
"entity_id": "ent_019eb6f6-2c34-7440-ab0c-3adadece977e"
}
]
}